
URAC is poised to grant accreditation to four companies for their pharmacy benefit management and/or drug therapy management programs.

URAC is poised to grant accreditation to four companies for their pharmacy benefit management and/or drug therapy management programs.

FutureScripts, a new pharmacy benefit manager in Philadelphia, is on the growth track

The Agency for Healthcare Research and Quality has proposed new rules for implementing the Patient Safety Act.

Good Neighbor Pharmacy will endow a chair in entrepreneurial pharmacy practice at the University of the Pacific in California.

A survey of pharmacists and physicians at managed care companies finds that they believe Vytorin use will drop but coverage will remain the same.

Mylan's generic levothyroxine removed from Florida's negative formulary.

Chattem's Icy Hot Heat Therapy products have been linked to burns and are being recalled

Dexamethasone increases fatigue in children; altering dosing could improve quality of life for patients and their families.

ASCO has updated its guidelines on deep vein thrombosis.

Antibiotic-resistant germ forcing hospitals, community to seek new ways to control infection.

NHIA's new executive director Russell Bodoff talks to Drug Topics about his organization's goals.

NHIA's new executive director Russell Bodoff talks to Drug Topics about his organization's goals.

New over the counter sleep aids.

What pharmacists need to know about FDA's toll free number for reporting adverse events rule.

Pharmacists push innovative medication therapy management models.

Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.

April 1 is the deadline for all Medicaid prescriptions to be written on tamper-resistant Rx pads.

Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.

Industry supports FDAs decision against OTC cough and cold medicines for children under two

Mycamine from Astellas Pharma was given a supplemental indication approval

Sandoz's Omnitrope Pen 5 has been cleared for treating kids with growth failure and adults with growth hormone deficiency on a long-term basis

Colesevelam approved for new indication

Patients asking pharmacists about Vytorin controversy

Etravirine approved for treatment of HIV

The proposed First DataBank settlement that would have discontinued AWP has been denied by a federal court judge.

The Clinic at Wal-Mart to open in Atlanta, Little Rock, and Dallas.

The National Council for Prescription Drug Programs is exploring the issue of what standards should be established for electronic medication administration records in long-term care.

Merck's $650 million settlement for two Medicaid fraud suits is expected to yield a windfall for participants in the 340B drug discount program.

The American Society of Addiction Medicine urges physicians to prescribe opioids with care following the death of actor Heath Ledger.

New Mexico to vote on dispensing fee bill.